Management of COVID-19 in Kidney Transplant Recipients: A Single-Center Case Series

Keyphrases

• Single Center 100%
• Kidney Transplant Recipients 100%
• COVID-19 100%
• Mortality Rate 21%
• Non-survivors 14%
• Management Strategy 14%
• Immunosuppressive Therapy 14%
• Acute Kidney Injury 14%
• Indonesian 7%
• Indonesia 7%
• High Risk 7%
• Antiretroviral Therapy 7%
• Radiological Assessment 7%
• D-dimer 7%
• Fever 7%
• Vaccination 7%
• Clinical Presentation 7%
• Nineteen 7%
• Laboratory Examination 7%
• Presenting Symptoms 7%
• Laboratory Parameters 7%
• Unvaccinated 7%
• Anticoagulants 7%
• Shortness of Breath 7%
• Cough 7%
• Anamnesis 7%
• Severe Coronavirus Disease 2019 7%
• Physical Laboratory 7%
• Intravenous Immunoglobulin (IVIg) 7%
• Transplant Center 7%
• Vaccination Status 7%
• Intravenous Tocilizumab 7%
• Hypercoagulation 7%
• Short-term Clinical Outcomes 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Coronavirinae 100%
• Diseases 100%
• Mortality Rate 33%
• Immunosuppressive Agent 22%
• Acute Kidney Failure 22%
• Immunoglobulin 11%
• Anticoagulant Agent 11%
• Coughing 11%
• Dyspnea 11%
• Antiviral Therapy 11%
• D Dimer 11%
• Tocilizumab 11%

Medicine and Dentistry

• Kidney Graft 100%
• COVID-19 100%
• Mortality Rate 21%
• Immunosuppressive Treatment 14%
• Acute Kidney Injury 14%
• Radiodiagnosis 7%
• Immunoglobulin 7%
• Antithrombotic 7%
• Physical Examination 7%
• Laboratory Test 7%
• Dyspnea 7%
• Coughing 7%
• Antiviral Therapy 7%
• Anamnesis 7%
• D-Dimer 7%
• Tocilizumab 7%